ProfileGDS4718 / 207979_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 63% 56% 61% 57% 68% 65% 63% 63% 59% 63% 61% 57% 59% 69% 60% 63% 54% 53% 51% 62% 64% 68% 55% 62% 69% 59% 76% 54% 62% 58% 68% 69% 65% 73% 87% 56% 70% 62% 58% 59% 54% 60% 82% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1327860
GSM549102patient 115, normal, homogenized [OPG study]6.3594463
GSM549104patient 119, normal, homogenized [OPG study]5.8567856
GSM549108patient 138, normal, homogenized [OPG study]6.23361
GSM549119patient 077, normal, homogenized [OPG study]5.9134757
GSM549133patient 032, cancer, homogenized [OPG study]6.7787468
GSM549139patient 042, cancer, homogenized [OPG study]6.500465
GSM549099patient 107, normal, homogenized [OPG study]6.3165863
GSM549109patient 139, normal, homogenized [OPG study]6.3436363
GSM549110patient 046, normal, homogenized [OPG study]6.0840459
GSM549114patient 063, normal, homogenized [OPG study]6.27563
GSM549122patient 082, normal, homogenized [OPG study]6.215161
GSM549134patient 033, cancer, homogenized [OPG study]5.8971957
GSM549136patient 036, cancer, homogenized [OPG study]6.0144759
GSM549140patient 044, cancer, homogenized [OPG study]6.831669
GSM549111patient 047, normal, homogenized [OPG study]6.1341960
GSM549113patient 057, normal, homogenized [OPG study]6.2844463
GSM549132patient 031, cancer, homogenized [OPG study]5.7517254
GSM549137patient 038, cancer, homogenized [OPG study]5.6499953
GSM549142patient 047, cancer, homogenized [OPG study]5.7063251
GSM549100patient 110, normal, homogenized [OPG study]6.2611862
GSM549107patient 135, normal, homogenized [OPG study]6.3958164
GSM549115patient 068, normal, homogenized [OPG study]6.7212168
GSM549116patient 072, normal, homogenized [OPG study]5.7878255
GSM549120patient 078, normal, homogenized [OPG study]6.2379362
GSM549131patient 030, cancer, homogenized [OPG study]6.8548269
GSM549118patient 074, normal, homogenized [OPG study]6.0509859
GSM549129patient 027, cancer, homogenized [OPG study]7.4672776
GSM549123patient 088, normal, homogenized [OPG study]5.7445554
GSM549124patient 006, cancer, homogenized [OPG study]6.2825262
GSM549126patient 015, cancer, homogenized [OPG study]5.9646658
GSM549128patient 025, cancer, homogenized [OPG study]6.7556868
GSM549103patient 117, normal, homogenized [OPG study]6.7537769
GSM549117patient 073, normal, homogenized [OPG study]6.4064665
GSM549138patient 041, cancer, homogenized [OPG study]7.1849873
GSM549141patient 045, cancer, homogenized [OPG study]8.8806287
GSM549130patient 028, cancer, homogenized [OPG study]5.8572956
GSM549101patient 111, normal, homogenized [OPG study]6.871370
GSM549105patient 128, normal, homogenized [OPG study]6.2502762
GSM549106patient 134, normal, homogenized [OPG study]5.9718858
GSM549112patient 048, normal, homogenized [OPG study]6.0728559
GSM549125patient 011, cancer, homogenized [OPG study]5.7531554
GSM549127patient 024, cancer, homogenized [OPG study]6.168460
GSM549135patient 035, cancer, homogenized [OPG study]8.1749482